“…Literature has described 1,2,3-triazole compound as an important class of five-member nitrogen heterocyclic system which exhibits different pharmacological profiles, such as antiplatelet activity [15], anticlotting [16], antiviral [17], trypanocidal [18], antimicrobial [19], and/or their use in treating schizophrenia [20] and leishmaniasis [21]. Two general methods are available for the construction of 1,2,3-triazole rings: Huisgen 1,3-dipolar cycloaddition reactions [22], in particular the copper(I)-catalyzed cycloaddition [23], and the intramolecular 1,5-electrocyclization of β -substituted- α -diazocarbonyl compounds [24]. Our previous studies have indicated that six new synthetic 1,2,3-triazole compounds (1-arylsulfonylamino-5-methyl-1 H -[1,2, 3]-triazole-4-carboxylic acid ethyl esters) inhibited the hemolysis induced by L. muta venom [25].…”